This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Increasing Surgical Volumes To Boost Use Of Tissue Sealants And Topical Haemostats, Says Frost & Sullivan





LONDON, Feb. 13, 2013 /PRNewswire/ -- The need for quality care, especially for a rapidly ageing population, is a strong driving factor for the tissue sealants and haemostats market in Western Europe. Technologically advanced products that enhance surgical efficiency and patient safety will also boost market prospects.

New analysis from Frost & Sullivan ( http://www.healthcare.frost.com), Western European Tissue Sealants and Topical Hemostats Market, finds that the market earned revenues of $438.1 million in 2011 and estimates this to reach $685.5 million in 2016. The research covers tissue sealants (fibrin and synthetic) and topical haemostats (gelatine-based, collagen-based, thrombin-based, oxidized-regenerated cellulose-based and combination).

"The demand for tissue sealants and topical haemostats products is directly proportional to the total number of surgical procedures performed," notes Frost & Sullivan Research Analyst Brahadeesh Chandrasekaran. "As Europe's population ages, the volume and range of surgical procedures conducted is set to increase. This will promote demand for tissue sealants and topical haemostats, because both peri-operative and post-operative bleeding requires immediate attention during complex surgeries."

Product innovation – such as sealants with drug-delivery applications or novel applicator systems that improve ease-of-use for surgeons – will further encourage the uptake of tissue sealants and topical haemostats. Another positive trend is the development of recombinant- and plant-based and combinatory products. Such products are set to address patient safety concerns that are currently impeding market growth.

At present, most sealants and haemostats are used with high benefits and no complications. In some cases, however, there have been concerns related to biocompatibility and infection-associated risks. This is because some products contain animal-derived components, while others derived from human plasma are subject to the risk of transmission of viral diseases inherent in plasma-derived products.

"This has triggered significant growth in plant-based and combinatory products, because they have proven to be safe for patients," remarks Chandrasekaran. "Manufacturers that already have green or plant-based products have an edge, provided their products are backed by strong clinical evidence."

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs